rs140006150
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The ENST00000409170.3(RPL36A-HNRNPH2):c.300+2092C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.000011 ( 0 hom., 0 hem., cov: 20)
Consequence
RPL36A-HNRNPH2
ENST00000409170.3 intron
ENST00000409170.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -3.08
Publications
0 publications found
Genes affected
RPL36A-HNRNPH2 (HGNC:48349): (RPL36A-HNRNPH2 readthrough) This locus represents naturally occurring read-through transcription between the neighboring ribosomal protein L36a and heterogeneous nuclear ribonucleoprotein H2 (H') genes on chromosome X. The read-through transcript produces a protein with similarity to the protein encoded by the upstream locus, ribosomal protein L36a. Alternatively spliced transcript variants have been identified. [provided by RefSeq, Jan 2011]
GLA (HGNC:4296): (galactosidase alpha) This gene encodes a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties. [provided by RefSeq, Jul 2008]
GLA Gene-Disease associations (from GenCC):
- Fabry diseaseInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000105 AC: 1AN: 95156Hom.: 0 Cov.: 20 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
95156
Hom.:
Cov.:
20
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0000105 AC: 1AN: 95156Hom.: 0 Cov.: 20 AF XY: 0.00 AC XY: 0AN XY: 24388 show subpopulations
GnomAD4 genome
AF:
AC:
1
AN:
95156
Hom.:
Cov.:
20
AF XY:
AC XY:
0
AN XY:
24388
show subpopulations
African (AFR)
AF:
AC:
0
AN:
19609
American (AMR)
AF:
AC:
0
AN:
9020
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2584
East Asian (EAS)
AF:
AC:
0
AN:
3265
South Asian (SAS)
AF:
AC:
0
AN:
2084
European-Finnish (FIN)
AF:
AC:
0
AN:
5087
Middle Eastern (MID)
AF:
AC:
0
AN:
205
European-Non Finnish (NFE)
AF:
AC:
1
AN:
51339
Other (OTH)
AF:
AC:
0
AN:
1306
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.